| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | ACPT-I |
|---|
| Description | An mGluR4a and mGluR8 agonist (EC50s = 7.2 and 8.2 μM, respectively); has no effect on mGluR1a or mGluR2; reduces cell death following oxygen-glucose deprivation in primary neuronal cultures using concentrations of 1-200 μM; reduces cell death in a rat model of middle cerebral artery occlusion when used at a dose of 30 mg/kg; reduces the incidence of clonic seizures in various seizure models in mice and rats (ED50s = 0.08-49.3 nM, i.c.v.); has anxiolytic-like effects in mice and rats that can be blocked by 5-HT1A and GABAA receptor antagonists |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | ACPTI mGluR-4a 8 1a 2 anti-convulsant WAY100635 5HT 5HT1A GABA-A |
|---|
| Gene, Accession, CAS # | CAS: 194918-76-8 |
|---|
| Catalog # | 78010-25 |
|---|
| Price | |
|---|
| Order / More Info | ACPT-I from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|